A proposal that would restructure how New Jersey regulates medical and adult-use marijuana was given approval today by the Senate Budget and Appropriations Committee in a vote of 9 to 1 vote (with three abstentions).
The bill, introduced last month by Senator Nicholas Scutari’s (D), would redraw several internal rules for the Cannabis Regulatory Commission while easing the path for medical dispensaries seeking adult-use approval.
The measure updates the appointment and governance structure of the five-member Cannabis Regulatory Commission, shifting the designation of the chair from a gubernatorial appointment to a majority vote of commissioners. It would also raise salary caps, allow commissioners who hold local elected office to campaign and fundraise during election years, and clarify that commissioners may meet with stakeholders outside commission premises as long as those meetings are properly logged.
Another major component concerns licensing. Under the proposal, medical dispensaries operating without violations for at least 180 days would be shielded from municipal attempts to block their transition into adult-use sales. The bill also eliminates the requirement that these dispensaries obtain new rounds of municipal approval when applying for or renewing a Class 5 cannabis retailer license at the same location, a change intended to streamline conversions in municipalities that already host medical operators.
Municipal authority is also addressed. The bill reasserts local power to regulate cannabis businesses but limits municipalities from prohibiting dispensaries that already operate legally. In addition, it strengthens enforcement against the unlicensed market by directing the New Jersey State Police, local agencies, and the Attorney General’s Office to coordinate investigations and shutdowns of illegal cannabis businesses deemed public nuisances.
Ethics provisions tied to the commission are further revised. The bill narrows certain prohibitions on employment and political activity while maintaining conflict-of-interest safeguards, expanding exceptions for situations where the State Ethics Commission determines no reasonable risk to impartiality exists. These adjustments create a more flexible framework for commissioners and staff while keeping intact restrictions intended to preserve independence from the industry they regulate.
With today’s committee approval, the legislation moves closer to a full Senate vote. Supporters argue the changes will modernize the state’s regulatory structure and help medical dispensaries participate more efficiently in the adult-use market. Opponents raised concerns about weakening ethical boundaries and diminishing local control, though the bill retains key prohibitions designed to prevent direct financial entanglements between commissioners and cannabis businesses.
If passed into law, the proposal is scheduled to take effect May 1, 2026.
More articles from The Marijuana Herald can be found below.
